246
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Adherence to Treatment and Glycemic Control in Patients with Type 2 Diabetes Mellitus: A 4-Year Follow-up PTM Bogor Cohort Study, Indonesia

, , , & ORCID Icon
Pages 2467-2477 | Published online: 06 Nov 2021

References

  • International Diabetes Federation. IDF Diabetes Atlas Ninth Edition 2019. International Diabetes Federation; 2019. Available from: https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed November 14, 2020.
  • Soelistijo SA, Lindarto D, Decroli E, et al. Pedoman Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Dewasa [Guidelines for the Management and Prevention of Type 2 Diabetes Mellitus in Adults]. PB PERKENI; 2019. Indonesian.
  • Badan Penelitian dan Pengembangan Kesehatan [National Institute of Health Research and Development, Ministry of Health, Republic of Indonesia]. Laporan nasional riskesdas 2018 [Basic Health Research Report 2018]. Kementerian Kesehatan Republik Indonesia; 2019. Available from: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf. Accessed November 14, 2020. Indonesian.
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes. In: Standards of Medical Care in Diabetes - 2020. Vol. 43. American Diabetes Association;2020:S14–S31. Available from: https://care.diabetesjournals.org/content/43/Supplement_1/S14. Accessed October 6, 2021.
  • Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A. The DiabCare Asia 2008 study – outcomes on control and complications of type 2 diabetic patients in Indonesia. Med J Indones. 2010;19(4):235–244. doi:10.13181/mji.v19i4.412
  • Ligita T, Wicking K, Francis K, Harvey N, Nurjannah I. How people living with diabetes in Indonesia learn about their disease: a grounded theory study. PLoS One. 2019;14(2):e0212019. doi:10.1371/journal.pone.0212019
  • Mafauzy M. Diabetes mellitus in Malaysia. Med J Malaysia. 2006;61(4):397–398.
  • Kalogianni A. Factors affect in patient adherence to medication regimen. Health Sci J. 2011;5:157–158.
  • Aloudah NM, Scott NW, Aljadhey HS, Araujo-Soares V, Alrubeaan KA, Watson MC. Medication adherence among patients with type 2 diabetes: a mixed methods study. PLoS One. 2018;13(12):e0207583. doi:10.1371/journal.pone.0207583
  • Adikusuma W, Qiyaam N. Adherence level and blood sugar control of type 2 diabetes mellitus patients who gets counseling and short messages service as reminder and motivation. Asian J Pharm Clin Res. 2018;11(2):219. doi:10.22159/ajpcr.2018.v11i2.22988
  • Aminde LN, Tindong M, Ngwasiri CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35. doi:10.1186/s12902-019-0360-9
  • Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a Cross Sectional Study. BMC Health Serv Res. 2015;15(1):168. doi:10.1186/s12913-015-0820-5
  • Basu S, Garg S, Sharma N, Singh MM, Garg S. Adherence to self-care practices, glycemic status and influencing factors in diabetes patients in a tertiary care hospital in Delhi. World J Diabetes. 2018;9(5):72–79. doi:10.4239/wjd.v9.i5.72
  • Almeida C, Rocha C, Cruz R. Impact of adverse effects to oral antidiabetics on adherence and quality of life in patients with type 2 diabetes. Eur J Public Health. 2020;30(Supplement_2). doi:10.1093/eurpub/ckaa040.020
  • Mohamed MR, Ramsdale E, Loh KP, et al. Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta‐analysis. Oncologist. 2020;25(1):e94–e108. doi:10.1634/theoncologist.2019-0406
  • Lwanga SK, Lemeshow S; World Health Organization. Sample size determination in health studies: a practical manual. World Health Organization; 1991. Available from: https://apps.who.int/iris/handle/10665/40062. Accessed March 3, 2021.
  • Kshanti IAM, Wibudi A, Sibarani RP, et al. Pedoman pengelolaan glukosa darah mandiri [Guidelines for self-management of blood glucose]. PB PERKENI; 2019. Available from: https://pbperkeni.or.id/wp-content/uploads/2019/12/Pedoman-Pengelolaan-Glukosa-Darah-Mandiri-2019.pdf. Accessed November 15, 2020. Indonesian.
  • Javed R, Mohsin SN, Adnan M, Naz S. Prevalence of type 2 diabetes among asymptomatic adults of Lahore Pakistan. Iran J Sci Technol Trans Sci. 2019;43(5):2185–2192. doi:10.1007/s40995-019-00747-9
  • Omar SM, Musa IR, ElSouli A, Adam I. Prevalence, risk factors, and glycaemic control of type 2 diabetes mellitus in eastern Sudan: a community-based study. Ther Adv Endocrinol Metab. 2019;10:2042018819860071. doi:10.1177/2042018819860071
  • Shao Y, Liang L, Shi L, Wan C, Yu S. The effect of social support on glycemic control in patients with type 2 diabetes mellitus: the mediating roles of self-efficacy and adherence. J Diabetes Res. 2017;2017:2804178. doi:10.1155/2017/2804178
  • Felix HC, Narcisse MR, Long CR, McElfish PA. Effects of a family diabetes self-management education intervention on the patients’ supporters. Fam Syst Health. 2020;38(2):121–129. doi:10.1037/fsh0000470
  • Kim S, Song Y, Park J, Utz S. Patients’ experiences of diabetes self-management education according to health-literacy levels. Clin Nurs Res. 2020;29(5):285–292. doi:10.1177/1054773819865879
  • Huang Y-M, Pecanac KE, Shiyanbola OO. “Why am i not taking medications?” Barriers and facilitators of diabetes medication adherence across different health literacy levels. Qual Health Res. 2020;30(14):2331–2342. doi:10.1177/1049732320945296
  • Lilyana MTA, Pae K. Effectiveness education for diabetic melitus management in elderly with diabetic melitus. Adi Husada Nurs J. 2020;6(1):1–7. doi:10.37036/ahnj.v6i1.156
  • Pruette CS, Amaral S. Empowering patients to adhere to their treatment regimens: a multifaceted approach. Pediatr Transplant. 2020;e13849–e13849. doi:10.1111/petr.13849
  • Tiktin M, Celik S, Berard L. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Curr Med Res Opin. 2016;32(2):277–287. doi:10.1185/03007995.2015.1119677
  • Mert KU, Başaran Ö, Mert GÖ, et al. Management of LDL-cholesterol levels in patients with diabetes mellitus in cardiology practice: real life evidence of under-treatment from the EPHESUS registry. Eur J Clin Invest. 2021:e13528. doi:10.1111/eci.13528
  • Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–971. doi:10.1210/jcem.86.3.7304
  • Haider K, Rehman K, Akash MSH. Impaired lipid metabolism in metabolic disorders. In: Akash MSH, Rehman K, Hashmi MZ, editors. Endocrine Disrupting Chemicals-Induced Metabolic Disorders and Treatment Strategies. Emerging Contaminants and Associated Treatment Technologies. Springer International Publishing; 2021:83–94. doi:10.1007/978-3-030-45923-9_5
  • Khan HA, Sobki SH, Khan SA. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: hbA1c predicts dyslipidaemia. Clin Exp Med. 2007;7(1):24–29. doi:10.1007/s10238-007-0121-3
  • Widyasari N. Hubungan karakteristik responden dengan risiko diabetes melitus dan dislipidemia kelurahan tanah kalikedinding [The relationship between respondent characteristics and the risk of diabetes mellitus and dyslipidemia in Tanah Kalikedinding Village [Relationship of Respondent’s Characteristic with The Risk of Diabetes Mellitus and Dislipidemia at Tanah Kalikedinding]. Per Epid J. 2017;5(1):130–141. Indonesian. doi:10.20473/jbe.V5I12017.130-1413
  • Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015;39(5):353–362. doi:10.4093/dmj.2015.39.5.353
  • García-Molina L, Lewis-Mikhael A-M, Riquelme-Gallego B, Cano-Ibáñez N, Oliveras-López M-J, Bueno-Cavanillas A. Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysis. Eur J Nutr. 2020;59(4):1313–1328. doi:10.1007/s00394-019-02147-6
  • Acuña-Zegarra MA, Santana-Cibrian M, Velasco-Hernandez JX. Modeling behavioral change and COVID-19 containment in Mexico: a trade-off between lockdown and compliance. Math Biosci. 2020;325:108370. doi:10.1016/j.mbs.2020.108370
  • Sakitri G, Astuti RK. Strategi kontrol gula darah dengan theory of planned behaviour pada pasien diabetes mellitus tipe 2 di puskesmas stabelan [Blood sugar control strategy with the theory of planned behavior in patients with type 2 diabetes mellitus at a Stabelan Health Center]. Profesi Prof Islam Media Publ Penelit. 2020;18(1):55–63. Indonesian. doi:10.26576/profesi.v18i1.42
  • Sagala R, Arozal W, Sauriasari R, Keban S. Evaluasi penerapan booklet dan edukasi apoteker pada pasien diabetes melitus tipe 2 di rumah sakit mayapada tangerang [Evaluation of the application of booklets and pharmacist education in patients with type 2 diabetes mellitus at the Mayapada Hospital, Tangerang]. Pharm Sci Res. 2018;4(2). Indonesian. doi:10.7454/psr.v4i2.3742